Vincenza Nigro
Corporate Officer/Principal bei HANSA BIOPHARMA AB
Aktive Positionen von Vincenza Nigro
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HANSA BIOPHARMA AB | Corporate Officer/Principal | 17.09.2018 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 17.09.2018 | - |
Karriereverlauf von Vincenza Nigro
Ehemalige bekannte Positionen von Vincenza Nigro
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Vincenza Nigro
| Fairleigh Dickinson University | Undergraduate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 3 |
| Dänemark | 2 |
| Schweden | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Börse
- Insiders
- Vincenza Nigro
- Erfahrung
